News & Perspective

Oct 02, 2012

May 04, 2006

May 04, 2006

US awards $1 billion for cell-based flu vaccines

Robert Roos
 |
May 04, 2006

(CIDRAP News) – In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.

Jan 20, 2006

Jan 20, 2006

Report discourages use of antivirals for seasonal flu

Robert Roos
 |
Jan 20, 2006

Jan 20, 2005 (CIDRAP News) – Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flu—a recommendation flatly rejected by the manufacturer of oseltamivir.

Current Results

3 items

Content Type

by Topic

by date

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»